Gene therapy for monogenic disorders of the bone marrow. (2015)
Attributed to:
Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.13520
PubMed Identifier: 26044877
Publication URI: http://europepmc.org/abstract/MED/26044877
Type: Journal Article/Review
Volume: 171
Parent Publication: British journal of haematology
Issue: 2
ISSN: 0007-1048